🔬

Antimicrobial Resistance

2
Open Unknowns
1
Cross-Domain Bridges
2
Active Hypotheses

Cross-Domain Bridges

Bridge Extreme-value theory offers a common tail-risk language for antimicrobial-resistance emergence surveillance.

Fields: Statistics, Epidemiology, Antimicrobial Resistance

Speculative analogy: Extreme-value theory offers a common tail-risk language for antimicrobial-resistance emergence surveillance....

Open Unknowns (2)

Unknown Can the rate of antibiotic resistance evolution to a novel antibiotic be predicted before clinical deployment ΓÇö and what antibiotic features (target essentiality, mechanism of action, penetration, efflux susceptibility) best predict resistance emergence timelines? u-antibiotic-resistance-evolution-rate-clinical-deployment
Unknown What validation boundary conditions determine when `b-extreme-value-theory-x-antimicrobial-resistance-surveillance` remains decision-useful? u-threshold-selection-bias-in-evt-based-amr-early-warning

Active Hypotheses

Hypothesis Transferred methods from `b-extreme-value-theory-x-antimicrobial-resistance-surveillance` improve target outcomes versus domain-specific baselines at matched cost. high
Hypothesis Phage-antibiotic combination therapy (PAC) will suppress resistance evolution in ESKAPE pathogens beyond either component alone ΓÇö because phage resistance mutations (receptor loss) restore antibiotic susceptibility via evolutionary trade-offs ΓÇö making PAC a self-sterilizing therapeutic strategy. high

Know something about Antimicrobial Resistance? Contribute an unknown or hypothesis →

Generated 2026-05-10 · USDR Dashboard